期刊
GREEN CHEMISTRY
卷 19, 期 13, 页码 2986-2991出版社
ROYAL SOC CHEMISTRY
DOI: 10.1039/c7gc00937b
关键词
-
资金
- Bill and Melinda Gates Foundation [OPP1108573]
- Clinton Health Access Initiative
- Bill and Melinda Gates Foundation [OPP1108573] Funding Source: Bill and Melinda Gates Foundation
Access to affordable medications continues to be one of the most pressing issues for the treatment of disease in developing countries. For many drugs, synthesis of the active pharmaceutical ingredient (API) represents the most financially important and technically demanding element of pharmaceutical operations. Furthermore, the environmental impact of API processing has been well documented and is an area of continuing interest in green chemical operations. To improve drug access and affordability, we have developed a series of core principles that can be applied to a specific API, yielding dramatic improvements in chemical efficiency. We applied these principles to nevirapine, the first non-nucleoside reverse transcriptase inhibitor used in the treatment of HIV. The resulting ultra-efficient (91% isolated yield) and highly-consolidated (4 unit operations) route has been successfully developed and implemented through partnerships with philanthropic entities, increasing access to this essential medication. We anticipate an even broader global health impact when applying this model to other active ingredients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据